Literature DB >> 22350696

Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan.

Susumu Take1, Motowo Mizuno, Kuniharu Ishiki, Takayuki Imada, Tetsuji Okuno, Tomowo Yoshida, Kenji Yokota, Keiji Oguma, Masahide Kita, Hiroyuki Okada, Kazuhide Yamamoto.   

Abstract

BACKGROUND: We previously reported that the reinfection rate with Helicobacter pylori in Japan was low despite a high prevalence of infection. In the present study, we extended our previous work to more accurately determine the reinfection rate.
METHODS: We enrolled 1625 patients (219 women and 1406 men, mean age 50.8 years) who had received H. pylori eradication therapy. After documentation of eradication, bacterial culture and urea breath test were carried out yearly. H. pylori strains were analyzed by using random amplification of polymorphic DNA fingerprinting.
RESULTS: A total of 1609 patients were followed for up to 12.5 years (mean 4.7 years); H. pylori became re-positive in 26 patients. In 13 of the 26 patients, H. pylori became positive at the first-year follow up. Stored H. pylori isolates were available for analysis from ten of the 13 patients; four of the isolates were genetically different from the initial strain, but the other six were identical to the initial strain. In the other 13 patients, H. pylori became positive at later follow up (mean 4.8 years; range 1.8-8.0 years). In all of the four of these patients whose isolates could be analyzed, the H. pylori strains were different from the initial strain. Assuming that reinfection occurred in the four patients positive for different strains of H. pylori at the first-year follow up and in the 13 positive at later follow up, the reinfection rate was 0.22% per year.
CONCLUSIONS: When probable recrudescence (H. pylori positivity with identical strains) was excluded, the reinfection rate of H. pylori in this Japanese population was very low, but we note that reinfection can occur over many years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350696     DOI: 10.1007/s00535-012-0536-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  38 in total

1.  The bacteria behind ulcers.

Authors:  M J Blaser
Journal:  Sci Am       Date:  1996-02       Impact factor: 2.142

2.  Reinfection rate following effective therapy against Helicobacter pylori infection in Japan.

Authors:  Masayasu Adachi; Motowo Mizuno; Kenji Yokota; Masatsugu Miyoshi; Yasuhiro Nagahara; Toshirou Maga; Kunihara Ishiki; Tomoki Inaba; Hioyuki Okada; Keiji Oguma; Takao Tsuji
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

3.  Relationship between progression of gastric mucosal atrophy and Helicobacter pylori infection: retrospective long-term endoscopic follow-up study.

Authors:  N Sakaki; T Arakawa; H Katou; K Momma; N Egawa; T Kamisawa; Y Yamada; Y Tu; C Ishikawa; J Ishiwata
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

4.  Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection.

Authors:  H M Malaty; T Kumagai; E Tanaka; H Ota; K Kiyosawa; D Y Graham; T Katsuyama
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan.

Authors:  T Inaba; M Mizuno; S Take; K Suwaki; T Honda; K Kawai; M Fujita; T Tamura; K Yokota; K Oguma; H Okada; Y Shiratori
Journal:  Eur J Clin Invest       Date:  2005-03       Impact factor: 4.686

6.  Oral cavity as a potential source of gastric reinfection by Helicobacter pylori.

Authors:  Elzbieta Karczewska; Joanna E Konturek; Peter C Konturek; Marta Cześnikiewicz; Edward Sito; Władysław Bielański; Nina Kwiecień; Wojciech Obtułowicz; Witold Ziemniak; Jolanta Majka; Eckhart G Hahn; Stanislaw J Konturek
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 7.  How is Helicobacter pylori transmitted?

Authors:  D R Cave
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

8.  Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.

Authors:  Susumu Take; Motowo Mizuno; Kuniharu Ishiki; Yasuhiro Nagahara; Tomowo Yoshida; Tomoki Inaba; Kazuhide Yamamoto; Hiroyuki Okada; Kenji Yokota; Keiji Oguma; Yasushi Shiratori
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

9.  Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria.

Authors:  B Wedi; S Wagner; T Werfel; M P Manns; A Kapp
Journal:  Int Arch Allergy Immunol       Date:  1998-08       Impact factor: 2.749

10.  Oral colonization of Helicobacter pylori: risk factors and response to eradication therapy.

Authors:  Ahmet Kemal Gürbüz; A Melih Ozel; Yusuf Yazgan; Murat Celik; Sükrü Yildirim
Journal:  South Med J       Date:  2003-03       Impact factor: 0.954

View more
  15 in total

1.  Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study.

Authors:  Susumu Take; Motowo Mizuno; Kuniharu Ishiki; Fumihiro Hamada; Tomowo Yoshida; Kenji Yokota; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2014-10-29       Impact factor: 7.527

Review 2.  Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.

Authors:  Sun-Young Lee
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

3.  Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey.

Authors:  Daniel C Steinemann; Marco Bueter; Marc Schiesser; Iakovos Amygdalos; Pierre-Alain Clavien; Antonio Nocito
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

Review 4.  Helicobacter pylori infection in Japan.

Authors:  Seiji Shiota; Kazunari Murakawi; Rumiko Suzuki; Toshio Fujioka; Yoshio Yamaoka
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-01       Impact factor: 3.869

5.  Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?

Authors:  Halil Rakici; Remzi Adnan Akdogan; Teslime Ayaz; Recep Bedir
Journal:  Gastroenterol Res Pract       Date:  2015-03-15       Impact factor: 2.260

Review 6.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

7.  Low Re-infection Rate of Helicobacter pylori after Successful Eradication in Thailand: A 2 Years Study

Authors:  Ratha Korn Vilaichone; Arti Wongcha Um; Peranart Chotivitayatarakorn
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

8.  Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps.

Authors:  Florent Ailloud; Xavier Didelot; Sabrina Woltemate; Gudrun Pfaffinger; Jörg Overmann; Ruth Christiane Bader; Christian Schulz; Peter Malfertheiner; Sebastian Suerbaum
Journal:  Nat Commun       Date:  2019-05-22       Impact factor: 14.919

Review 9.  Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication.

Authors:  Reina Ohba; Katsunori Iijima
Journal:  World J Gastrointest Oncol       Date:  2016-09-15

10.  Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data.

Authors:  Shinzo Hiroi; Kentaro Sugano; Shiro Tanaka; Koji Kawakami
Journal:  BMJ Open       Date:  2017-07-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.